Personal profile

Expertises

Experienced leader of large national and international randomized clinical trials in anaesthesiology. Founder of WARD 24/7 (Wireless Assessment of Respiratory and circulatory Distress) - developing a clinical support system for continuous wireless monitoring of vital signs.

Main research areas

Postoperative cardiopulmonary complications; remote automated continuous wireless monitoring; large multicentre randomized clinical trials; anaesthesiology and perioperative care; oxygen therapy; surgical site infection.

Current research

Clinical research in all sections of the anaesthesiological specialty (anaesthesia, intensive care, pain medicine and prehospital emergency care), and especially in the area of identification and prevention of cardiopulmonary complications. 

  • WARD-project (ward247.org)
  • Oxygen and postoperative complications
  • Prevention of myocardial injury after non-cardiac surgery (MINS)
  • SphenoPalatine Ganglion block for headache relief
  • Acute toxicology

Potential conflicts of interest

Founder of a start-up company, WARD24/7 ApS, with the aim of pursuing the regulatory and commercial activities of the WARD-project (Wireless Assessment of Respiratory and circulatory Distress, a project developing a clinical support system for continuous wireless monitoring of vital signs). WARD24/7 ApS has obtained license agreement for any WARD-project software and patents. One patent has been filed: “Wireless Assessment of Respiratory and circulatory Distress (WARD), EP 21184712.4 and EP 21205557.8

Fingerprint

Dive into the research topics where Christian Sylvest Meyhoff is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or